{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T16:34:55Z","timestamp":1757781295621,"version":"3.33.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"4-6","license":[{"start":{"date-parts":[[2007,12,12]],"date-time":"2007-12-12T00:00:00Z","timestamp":1197417600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Naunyn-Schmied Arch Pharmacol"],"published-print":{"date-parts":[[2008,6]]},"DOI":"10.1007\/s00210-007-0207-1","type":"journal-article","created":{"date-parts":[[2007,12,11]],"date-time":"2007-12-11T10:30:45Z","timestamp":1197369045000},"page":"463-471","source":"Crossref","is-referenced-by-count":9,"title":["In vivo characterization of muscarinic receptors in peripheral tissues: evaluation of bladder selectivity of anticholinergic agents to treat overactive bladder"],"prefix":"10.1007","volume":"377","author":[{"given":"Shuji","family":"Maruyama","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoki","family":"Hasuike","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuhiro","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shizuo","family":"Yamada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2007,12,12]]},"reference":[{"key":"207_CR1","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1046\/j.1464-410x.1998.00717.x","volume":"81","author":"P Abrams","year":"1998","unstructured":"Abrams P, Freeman R, Anderstr\u00f6m C, Mattiasson A (1998) Tolterodine, a new antimuscarinic agent: as effective but better tolerated than oxybutynin in patients with an overactive bladder. Br J Urol 81:801\u2013810","journal-title":"Br J Urol"},{"key":"207_CR2","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/S1474-4422(03)00622-7","volume":"3","author":"K-E Andersson","year":"2004","unstructured":"Andersson K-E (2004) Antimuscarinics for treatment of overactive bladder. The Lancet Neurol 3:46\u201353","journal-title":"The Lancet Neurol"},{"key":"207_CR3","doi-asserted-by":"crossref","first-page":"S80","DOI":"10.1038\/sj.bjp.0706560","volume":"147","author":"SS Hegde","year":"2006","unstructured":"Hegde SS (2006) Muscarinic receptors in the bladder: from basic research to therapeutics. Br J Pharmacol 147:S80\u2013S87","journal-title":"Br J Pharmacol"},{"key":"207_CR4","doi-asserted-by":"crossref","first-page":"2933","DOI":"10.1016\/j.lfs.2004.05.030","volume":"75","author":"K Hirano","year":"2004","unstructured":"Hirano K, Maruyama S, Kimura R, Kagawa Y, Yamada S (2004) In vivo identification and characterization of binding sites for selective serotonin reuptake inhibitors in mouse brain. Life Sci 75:2933\u20132945","journal-title":"Life Sci"},{"key":"207_CR5","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1007\/s007020050181","volume":"106","author":"R Hosoi","year":"1999","unstructured":"Hosoi R, Kobayashi K, Watanabe Y, Inoue O (1999) Evaluation of in vivo binding properties of 3H-NMPB and 3H-QNB in mouse brain. J Neural Trans 106:583\u2013592","journal-title":"J Neural Trans"},{"key":"207_CR6","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1007\/s003450100223","volume":"19","author":"H Madersbacher","year":"2001","unstructured":"Madersbacher H, M\u00fcrtz G (2001) Efficacy, tolerability and safety profile of propiverine in the treatment of the overactive bladder (non-neurogenic and neurogenic). World J Urol 19:324\u2013335","journal-title":"World J Urol"},{"key":"207_CR7","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1046\/j.1464-410x.1999.00251.x","volume":"84","author":"H Madersbacher","year":"1999","unstructured":"Madersbacher H, Halaska M, Voigt R, Alloussi S, H\u00f6fner K (1999) A placebo-controlled, multicentre study comparing the tolerability and efficacy of propiverine and oxybutynin in patients with urgency and urge incontinence. BJU International 84:646\u2013651","journal-title":"BJU International"},{"key":"207_CR8","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/s00210-006-0105-y","volume":"374","author":"MC Michel","year":"2006","unstructured":"Michel MC, Hedge SS (2006) Treatment of the overactive bladder syndrome with muscarinic receptor antagonists-a matter of metabolites? Naunyn-Schmiedebergs Arch Pharmacol 374:79\u201385","journal-title":"Naunyn-Schmiedebergs Arch Pharmacol"},{"key":"207_CR9","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1254\/fpj.87.557","volume":"87","author":"K Mayuzumi","year":"1986","unstructured":"Mayuzumi K, Watanabe K, Tamaru K, Kasama T (1986) Effects of oxybutynin hydrochloride on the urinary bladder and urethra in in situ preparations. Nippon Yakurigaku Zasshi 87:557\u2013571","journal-title":"Nippon Yakurigaku Zasshi"},{"key":"207_CR10","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S0014-2999(97)89661-6","volume":"327","author":"L Nilvebrant","year":"1997","unstructured":"Nilvebrant L, Andersson K-E, Gillberg PG, Stahl M, Sparf B (1997a) Tolterodine-a new bladder-selective antimuscarinic agent. Eur J Pharmacol 327:195\u2013207","journal-title":"Eur J Pharmacol"},{"key":"207_CR11","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1111\/j.1600-0773.1997.tb02064.x","volume":"81","author":"L Nilvebrant","year":"1997","unstructured":"Nilvebrant L, Gillberg PG, Sparf B (1997b) Antimuscarinic potency and bladder selectivity of PNU-200577, a major metabolite of tolterodine. Pharmacol Toxicol 81:169\u2013172","journal-title":"Pharmacol Toxicol"},{"key":"207_CR12","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1254\/fpj.94.173","volume":"94","author":"N Nomura","year":"1989","unstructured":"Nomura N, Kaneko S, Hamakawa T, Nagai M, Iriki M (1989) Effects of propiverine hydrochloride (P-4) and its metabolites on urinary bladder function in anesthetized rats. Nippon Yakurigaku Zasshi 94:173\u2013180","journal-title":"Nippon Yakurigaku Zasshi"},{"key":"207_CR13","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1248\/bpb.24.491","volume":"24","author":"T Oki","year":"2001","unstructured":"Oki T, Thoma A, Yamada S, Kimura R (2001) Muscarinic receptor binding characteristics in rat tissues after oral administration of oxybutynin and propiverine. Biol Pharam Bull 24:491\u2013495","journal-title":"Biol Pharam Bull"},{"key":"207_CR14","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.ejphar.2005.11.004","volume":"529","author":"T Oki","year":"2006","unstructured":"Oki T, Maruyama S, Takagi Y, Yamamura HI, Yamada S (2006) Characterization of muscarinic receptor binding and inhibition of salivation after oral administration of tolterodine in mice. Eur J Pharmacol 529:157\u2013163","journal-title":"Eur J Pharmacol"},{"key":"207_CR15","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1002\/(SICI)1099-081X(199903)20:2<91::AID-BDD162>3.0.CO;2-Y","volume":"20","author":"I P\u00e5hlman","year":"1999","unstructured":"P\u00e5hlman I, Gozzi P (1999) Serum protein binding of tolterodine and its major metabolites in humans and several animal species. Biopharm Drug Dispos 20:91\u201399","journal-title":"Biopharm Drug Dispos"},{"key":"207_CR16","first-page":"125","volume":"51","author":"I P\u00e5hlman","year":"2001","unstructured":"P\u00e5hlman I, D\u2019Argy R, Nilvebrant L (2001) Tissue distribution of tolterodine, a muscarinic receptor antagonist, and transfer into fetus and milk in mice. Arzneim Forsch\/Drug Res 51:125\u2013133","journal-title":"Arzneim Forsch\/Drug Res"},{"key":"207_CR17","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/0006-8993(79)91051-5","volume":"171","author":"RW Pelham","year":"1979","unstructured":"Pelham RW, Munsat TL (1979) Identification of direct competition for, and indirect influences on, striatal muscarinic cholinergic receptors: in vivo [3H]quinuclidinyl benzilate binding in rats. Brain Res 171:473\u2013480","journal-title":"Brain Res"},{"key":"207_CR18","first-page":"289","volume":"26","author":"H Postlind","year":"1998","unstructured":"Postlind H, Danielson A, Lindgren A, Andersson SH (1998) Tolterodine: a new muscarinic receptor antagonist, is metabolized by cytochrome P450 2D6 and 3A4 in human liver microsomes. Drug Metab Disp 26:289\u2013293","journal-title":"Drug Metab Disp"},{"key":"207_CR19","first-page":"417","volume":"41","author":"T Terai","year":"1991","unstructured":"Terai T, Deguchi Y, Ohtsuka M, Kumada S (1991) Effects of the anticholinergic drug prifinium bromide on urinary bladder contractions in rat in vivo and in guinea-pig in vitro. Arzneimittelforschung 41:417\u2013420","journal-title":"Arzneimittelforschung"},{"key":"207_CR20","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1177\/00912700122010528","volume":"41","author":"A Todorova","year":"2001","unstructured":"Todorova A, Vonderheid-Guth B, Dimpfel W (2001) Effects of tolterodine, trospium chloride, and oxybutynin on the central nervous system. J Clin Pharmacol 41:636\u2013644","journal-title":"J Clin Pharmacol"},{"key":"207_CR21","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1016\/S0024-3205(97)00881-3","volume":"61","author":"S Uchida","year":"1997","unstructured":"Uchida S, Yamada S, Nagai K, Deguchi Y, Kimura R (1997) Brain pharmacokinetics and in vivo receptor binding of 1,4-dihydropyridine calcium channel antagonists. Life Sci 61:2083\u20132090","journal-title":"Life Sci"},{"key":"207_CR22","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1023\/A:1007512426420","volume":"17","author":"S Uchida","year":"2000","unstructured":"Uchida S, Yamada S, Deguchi Y, Yamamoto M, Kimura R (2000) In vivo specific binding characteristics and pharmacokinetics of a 1,4-dihydropyridine calcium channel antagonist in the senescent mouse brain. Pharm Res 17:844\u2013850","journal-title":"Pharm Res"},{"key":"207_CR23","doi-asserted-by":"crossref","first-page":"2454","DOI":"10.1016\/j.lfs.2007.04.002","volume":"80","author":"S Uchida","year":"2007","unstructured":"Uchida S, Kurosawa S, Fujino (Oki) T, Kato Y, Nanri M, Yoshida K, Yamada S (2007) Binding activities by propiverine and its N-oxide metabolites of L-type calcium channel antagonist receptors in the rat bladder and brain. Life Sci 80:2454\u20132460","journal-title":"Life Sci"},{"key":"207_CR24","first-page":"701","volume":"249","author":"R Weizman","year":"1989","unstructured":"Weizman R, Weifman A, Kook KA, Vocci F, Deutsh SI, Paul SM (1989) Repeated swim stress alters brain benzodiazepine receptors measured in vivo. J Pharmacol Exp Ther 249:701\u2013707","journal-title":"J Pharmacol Exp Ther"},{"key":"207_CR25","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/s00210-006-0103-0","volume":"374","author":"M Wuest","year":"2006","unstructured":"Wuest M, Weiss A, Waelbroeck M, Braeter M, Kelly LU, Hakenberg OW, Ravens U (2006) Propiverine and metabolites: differences in binding to muscarinic receptors and in functional models of detrusor contraction. Naunyn-Schmiedebergs Arch Pharmacol 374:87\u201397","journal-title":"Naunyn-Schmiedebergs Arch Pharmacol"},{"key":"207_CR26","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1016\/S0022-3565(24)38308-9","volume":"289","author":"S Yamada","year":"1999","unstructured":"Yamada S, Ohkura T, Deguchi Y, Kimura R (1999) In vivo measurement by [3H]tamsulosin of \u03b11 adrenoceptors of in tissues in relation to the pharmacokinetics. J Pharmacol Exp Ther 289:1575\u20131583","journal-title":"J Pharmacol Exp Ther"},{"key":"207_CR27","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/S0022-3565(24)29676-2","volume":"296","author":"S Yamada","year":"2001","unstructured":"Yamada S, Ohkura T, Deguchi Y, Kimura R (2001) In vivo demonstration of \u03b11-adrenoceptor subtype selectivity of KMD-3213 in rat tissues. J Pharmacol Exp Ther 296:160\u2013167","journal-title":"J Pharmacol Exp Ther"},{"key":"207_CR28","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1016\/S0024-3205(01)01541-7","volume":"70","author":"S Yamada","year":"2002","unstructured":"Yamada S, Nakajima M, Kusaka T, Uchida S, Kimura R (2002) In vivo receptor binding of benidipine and amlodipine in mesenteric arteries other tissues of spontaneously hypertensive rats. Life Sci 70:1999\u20132011","journal-title":"Life Sci"},{"key":"207_CR29","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.lfs.2006.08.028","volume":"80","author":"S Yamada","year":"2006","unstructured":"Yamada S, Maruyama S, Takagi Y, Uchida S, Oki T (2006) In vivo demonstration of M3 muscarinic receptor subtype selectivity of darifenacin in mice. Life Sci 80:127\u2013132","journal-title":"Life Sci"},{"key":"207_CR30","first-page":"205","volume":"10","author":"Y Yamamoto","year":"1995","unstructured":"Yamamoto Y, Tsuda M, Uda K, Matsushita H, Shindo T, Kawaguchi Y (1995) Pharmacokinetic studies on propiverine hydrochloride. Metabolites in urinary bladder, other tissues and urine of rats. Xenobiotic Metabol Dispos 10:205\u2013210","journal-title":"Xenobiotic Metabol Dispos"},{"key":"207_CR31","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/0006-8993(74)90738-0","volume":"80","author":"HI Yamamura","year":"1974","unstructured":"Yamamura HI, Kuhar MJ, Snyder SH (1974) In vivo identification of muscarinic cholinergic receptor binding in rat brain. Brain Res 80:170\u2013176","journal-title":"Brain Res"}],"container-title":["Naunyn-Schmiedeberg's Archives of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-007-0207-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00210-007-0207-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-007-0207-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,23]],"date-time":"2025-01-23T14:21:46Z","timestamp":1737642106000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00210-007-0207-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,12,12]]},"references-count":31,"journal-issue":{"issue":"4-6","published-print":{"date-parts":[[2008,6]]}},"alternative-id":["207"],"URL":"https:\/\/doi.org\/10.1007\/s00210-007-0207-1","relation":{},"ISSN":["0028-1298","1432-1912"],"issn-type":[{"type":"print","value":"0028-1298"},{"type":"electronic","value":"1432-1912"}],"subject":[],"published":{"date-parts":[[2007,12,12]]}}}